Skip to form
The Cell & Gene Therapy World Asia 2025 Industry Survey is your chance to shape the event agenda and discussions. By sharing your insights on challenges, priorities, and emerging trends, you help us tailor the conference to address the industry's most pressing needs. Your input will guide the focus on key topics like R&D, manufacturing, commercialisation, and regulatory updates, ensuring the event delivers valuable content and fosters impactful collaborations.
First Name
*
Last Name
*
E-mail
*
Company name
*
Country
*
Please Select
Afghanistan
Åland
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
Central African Republic
Chad
Chile
China
Colombia
Comoros
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini (Swaziland)
Ethiopia
Faroe Islands
Fiji
Finland
France
French Guiana*
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Greenland
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast (Côte d'Ivoire)
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
No
North Korea
North Macedonia
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Republic of Congo
Romania
Russia
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
São Tomé and Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Yemen
Yes
Zambia
Zimbabwe
Phone Number
Profile
*
Please Select
Tech/ Service/ Solution Provider
Big Pharma
BioPharma
Academic/ Research
CMO/ CDMO
CRO
Healthcare
Media Partner
Non-Profit Organisation
Government/ Regulator
Associations/ Societies
Financial Institutions
Which areas of cell and gene therapy are most relevant to your work? Select all that apply
*
Research & Development (R&D)
Manufacturing & Scaling Up
Clinical Trials
Regulatory Compliance
Commercialisation & Market Access
Other (Please Specify Below)
Other: Areas of Relevance
Please specify the area/s of cell and gene therapy that are most relevant to you if none of the options above apply.
How is your organisation involved in the Asian cell and gene therapy industry or cryogenic logistics, and what unique contributions do you bring to the sector?
*
Please Select
Biopharma
Academic Research Institutes
Supplier of Materials/ Equipment
Manufacturer
Regulatory & Compliance Consulting
Other (Please Specify Below)
Other: Contributions to Asian CGT and/ or Cryogenic Logistics
Please specify how your organisation is involved in the Asian CGT and/ or cryogenic logistics sector if none of the options above apply.
What are the top challenges in your current work that you’d like addressed at the conference? Select all that apply
*
Advancing Clinical Trial Efficiency in the Region
Cost-Effective Manufacturing
Access to New technologies (e.g.: AI/ Automation/ Single-Use Systems)
Regulatory Harmonisation in APAC
Workforce & Skill Development
Supply Chain & Logistics for Advanced Therapies
In your opinion, which topic should be given the highest priority at the conference? Select all that apply.
*
R&D Breakthroughs
Strategies for Manufacturing Scale-Up
Navigating APAC's Regulatory Landscape
Successful Commercialisation Case Studies
APAC BioPharma Case Studies Sharing
Partnership Opportunities for Startups & Investors
Other (Please Specify Below)
Other: Topic Priority
Please specify the topic you believe should be given the highest priority at the conference if none of the options above apply.
Which therapeutic areas in cell and gene therapy should we prioritise for speaker invitations at the conference? Select all that apply.
*
CAR-T (Chimeric Antigen Receptor T-Cell Therapy)
Stem Cell Therapy
NK Cell Therapy
Gene Editing (e.g.: CRISPR/ TALEN)
AAV & Lentiviral Gene Therapies
Tumour-Infiltrating Lymphocyte (TIL) Therapy
mRNA & Lipid Nanoparticles
Cytogenic Logistics & Supply Chain Innovations
APAC Regulators
Other (Please Specify Beelow)
Other: CGT Therapeutic Areas
Please specify the CGT therapeutic areas you believe should be prioritised when inviting speakers if none of the options above apply.
How would you prefer these topics be addressed? Select all that apply.
*
Keynote Presentation by Leading APAC BioPharma
Case Study Presentations & Real-Life Case Studies
Panel Discussions with Diverse Stakeholders
Pre-Conference Workshops/ Focus Days
Networking Sessions (e.g.: Drinks Reception)
Wish List: Please list any companies you hope to connect with at #CGTWA2025 with a short explanation why where possible.
Do you have any suggestions for emerging or overlooked topics that should be included?
Would you like to receive updates on #CGTWA2025?
*
Yes
No
Submit Responses